Biohaven Statement Regarding Kleo Pharmaceuticals (Kleo): Thomas J. Lynch, Jr., MD, Appointed As Kleo Chairman Of The Board
– Kleo is a publication immuno-oncology company spun from Yale University creating next-generation bispecific compounds designed to emulate or enhance the action of biologics – Dr. Lynch was most…
News story posted on 2019-11-04T23:56:00.0000000Z
